Elimination of hepatitis C in Australia by 2030: a decade and counting
Aust Prescr
.
2021 Apr;44(2):36-37.
doi: 10.18773/austprescr.2021.003.
Epub 2021 Apr 1.
Author
Gregory J Dore
1
Affiliation
1
Infectious diseases physician, St Vincent's Hospital, Sydney.
PMID:
33911328
PMCID:
PMC8075743
DOI:
10.18773/austprescr.2021.003
No abstract available
Keywords:
direct-acting antiviral drugs; hepatitis C; hepatocellular carcinoma; liver disease.
Publication types
Editorial